Effect of recombinant human endostatin on antitumor efficacy of paclitaxel/gemcitabine/cisplatin (TGP) chemotherapy in the treatment of advanced urothelial carcinoma. Reported patterns of utilization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback